The Cigna Group (CI) Financials

$329.97 +0.53 (+0.16%)

Closing price 03:59 PM Eastern

Extended Trading

$327.90 -2.07 (-0.63%)

As of 05:27 PM Eastern

Annual Income Statements for The Cigna Group

This table shows The Cigna Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	1,867	2,237	2,637	5,104	8,458	5,370	6,704	5,164	3,434
Consolidated Net Income / (Loss)	1,843	2,232	2,646	5,120	8,489	5,420	6,782	5,372	3,778
Net Income / (Loss) Continuing Operations	1,843	2,232	2,646	5,120	8,489	5,420	6,782	5,372	3,778
Total Pre-Tax Income	2,979	3,606	3,581	6,570	10,868	6,790	8,397	5,513	5,269
Total Revenue	39,838	41,722	48,569	153,741	164,554	174,126	181,693	193,688	244,408
Net Interest Income / (Expense)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Interest Income	39,838	41,722	48,569	153,741	164,554	174,126	181,693	193,688	244,408
Net Realized & Unrealized Capital Gains on Investments	-	-84	1,399	1,565	5,397	1,606	2,330	-411	-1,740
Premiums Earned	-	-	36,113	39,714	42,627	41,154	39,916	44,237	45,996
Other Non-Interest Income	39,838	41,806	11,057	112,462	116,530	131,366	139,447	149,862	200,152
Total Non-Interest Expense	36,859	37,864	44,490	145,489	152,248	166,128	172,068	186,729	237,704
Property & Liability Insurance Claims	24,341	25,263	27,528	30,819	32,710	33,565	32,184	36,287	38,648
Other Operating Expenses	12,367	12,486	16,727	111,721	117,556	130,565	138,008	148,623	197,353
Amortization Expense	151	115	235	2,949	1,982	1,998	1,876	1,819	1,703
Nonoperating Income / (Expense), net	-	-252	-498	-1,682	-1,438	-1,208	-1,228	-1,446	-1,435
Income Tax Expense	1,136	1,374	935	1,450	2,379	1,370	1,615	141	1,491
Net Income / (Loss) Attributable to Noncontrolling Interest	-24	-5.00	9.00	16	31	50	78	208	344
Basic Earnings per Share	$7.31	$8.92	$10.69	$13.58	$23.17	$15.89	$21.66	$17.57	$12.25
Weighted Average Basic Shares Outstanding	-	250.89M	246.70M	375.80M	351.85M	320.95M	297.06M	292.36M	273.68M
Diluted Earnings per Share	$7.19	$8.77	$10.54	$13.44	$22.96	$15.75	$21.41	$17.39	$12.12
Weighted Average Diluted Shares Outstanding	-	250.89M	246.70M	375.80M	351.85M	320.95M	297.06M	292.36M	273.68M
Weighted Average Basic & Diluted Shares Outstanding	-	250.89M	246.70M	375.80M	351.85M	320.95M	297.06M	292.36M	273.68M
Cash Dividends to Common per Share	$0.00	$0.04	$0.04	$0.04	$0.04	$4.00	$4.48	$4.92	$5.60

This table shows The Cigna Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	2,757	1,193	1,267	1,460	1,408	1,029	-277	1,548	739	1,424
Consolidated Net Income / (Loss)	2,778	1,222	1,306	1,510	1,449	1,107	-212	1,629	825	1,536
Net Income / (Loss) Continuing Operations	2,778	1,222	1,306	1,510	1,449	1,107	-212	1,629	825	1,536
Total Pre-Tax Income	3,491	1,358	1,601	1,884	1,840	188	79	1,989	1,192	2,009
Total Revenue	46,934	45,364	46,461	48,612	49,013	49,602	55,400	60,475	62,686	65,847
Total Non-Interest Income	46,934	45,364	46,461	48,612	49,013	49,602	55,400	60,475	62,686	65,847
Net Realized & Unrealized Capital Gains on Investments	1,857	-	221	304	286	-1,222	-1,565	273	-923	475
Premiums Earned	9,586	-	11,025	11,039	10,998	11,175	11,603	11,454	11,436	11,503
Other Non-Interest Income	35,491	25,223	35,215	37,269	37,729	39,649	45,362	48,748	52,173	53,869
Total Non-Interest Expense	43,139	43,383	44,502	46,365	46,808	49,054	54,999	58,111	61,118	63,476
Property & Liability Insurance Claims	7,751	7,969	9,046	9,034	8,927	9,280	9,440	9,515	9,527	10,166
Other Operating Expenses	34,928	34,957	34,997	36,876	37,427	39,323	45,136	48,176	51,155	52,886
Amortization Expense	460	457	459	455	454	451	423	420	436	424
Nonoperating Income / (Expense), net	-304	-	-358	-363	-365	-360	-322	-375	-376	-362
Income Tax Expense	713	136	295	374	391	-919	291	360	367	473
Net Income / (Loss) Attributable to Noncontrolling Interest	21	29	39	50	41	78	65	81	86	112
Basic Earnings per Share	$9.07	$3.89	$4.28	$4.96	$4.79	$3.54	($0.97)	$5.51	$2.65	$5.06
Weighted Average Basic Shares Outstanding	305.74M	297.06M	295.87M	295.98M	292.62M	292.36M	284.07M	279.55M	278.15M	273.68M
Diluted Earnings per Share	$8.97	$3.82	$4.24	$4.92	$4.74	$3.49	($0.97)	$5.45	$2.63	$5.01
Weighted Average Diluted Shares Outstanding	305.74M	297.06M	295.87M	295.98M	292.62M	292.36M	284.07M	279.55M	278.15M	273.68M
Weighted Average Basic & Diluted Shares Outstanding	305.74M	297.06M	295.87M	295.98M	292.62M	292.36M	284.07M	279.55M	278.15M	273.68M

This table details how cash moves in and out of The Cigna Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	1,217	-213	907	1,556	4,834	-4,697	428	2,361	594
Net Cash From Operating Activities	4,026	4,086	3,770	9,485	10,350	7,191	8,656	11,813	10,363
Net Cash From Continuing Operating Activities	4,026	4,086	3,770	9,485	10,350	7,191	8,656	11,813	10,363
Net Income / (Loss) Continuing Operations	1,843	2,232	2,646	5,120	8,489	5,420	6,782	5,372	3,778
Consolidated Net Income / (Loss)	1,843	2,232	2,646	5,120	8,489	5,420	6,782	5,372	3,778
Depreciation Expense	610	566	695	3,651	2,802	2,923	2,937	3,035	2,775
Non-Cash Adjustments to Reconcile Net Income	-169	119	-761	-367	-4,153	1,904	585	1,577	2,713
Changes in Operating Assets and Liabilities, net	1,742	1,169	1,190	1,081	3,212	-3,056	-1,648	1,829	1,097
Net Cash From Investing Activities	-2,574	-1,703	-26,378	-734	2,976	-3,611	3,098	-5,174	-2,102
Net Cash From Continuing Investing Activities	-2,574	-1,703	-26,378	-734	2,976	-3,611	3,098	-5,174	-2,102
Purchase of Property, Leasehold Improvements and Equipment	-461	-471	-	-1,050	-1,094	-1,154	-1,295	-1,573	-1,406
Purchase of Investment Securities	-7,159	-7,332	-31,821	-6,506	-6,918	-8,267	-4,650	-6,436	-3,852
Divestitures	-	-	0.00	0.00	5,592	-61	4,835	13	521
Sale and/or Maturity of Investments	5,046	6,100	5,755	6,822	5,396	5,871	4,208	2,822	2,635
Net Cash From Financing Activities	-225	-2,651	23,515	-7,187	-8,533	-8,212	-11,240	-4,294	-7,647
Net Cash From Continuing Financing Activities	-225	-2,651	23,515	-7,187	-8,533	-8,212	-11,240	-4,294	-7,647
Issuance of Debt	0.00	1,661	24,343	-681	4,863	5,235	0.00	1,491	4,462
Issuance of Common Equity	36	131	68	224	376	326	389	187	305
Repayment of Debt	-148	-1,563	-131	-4,494	-9,599	-4,714	-2,559	-1,769	-3,402
Repurchase of Common Equity	-139	-2,725	-342	-1,987	-4,042	-7,742	-7,607	-2,284	-7,034
Payment of Dividends	0.00	0.00	-	-15	-15	-1,341	-1,384	-1,450	-1,567
Other Financing Activities, Net	26	-155	-423	-234	-116	24	-79	-469	-411
Effect of Exchange Rate Changes	-10	55	-	-	41	-65	-86	16	-20
Cash Interest Paid	244	240	267	1,645	1,439	1,253	1,229	1,330	1,342
Cash Income Taxes Paid	1,064	1,036	1,019	1,776	1,837	2,240	1,850	1,471	898

This table details how cash moves in and out of The Cigna Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	2,194	-1,141	2,013	1,647	-1,090	-209	1,807	-2,687	-273	1,747
Net Cash From Operating Activities	3,283	2,099	5,028	2,492	2,826	1,467	4,840	265	46	5,212
Net Cash From Continuing Operating Activities	3,283	2,099	5,028	2,492	2,826	1,467	4,840	265	46	5,212
Net Income / (Loss) Continuing Operations	2,778	1,222	1,306	1,510	1,449	1,107	-212	1,629	825	1,536
Consolidated Net Income / (Loss)	2,778	1,222	1,306	1,510	1,449	1,107	-212	1,629	825	1,536
Depreciation Expense	726	735	749	755	766	765	741	738	650	646
Non-Cash Adjustments to Reconcile Net Income	-285	459	595	982	738	-738	1,855	48	9,987	-9,177
Changes in Operating Assets and Liabilities, net	64	-317	2,378	-755	-127	333	2,456	-2,150	-11,416	12,207
Net Cash From Investing Activities	4,446	-616	-2,983	-414	-1,337	-440	-495	-640	-776	-191
Net Cash From Continuing Investing Activities	4,446	-616	-2,983	-414	-1,337	-440	-495	-640	-776	-191
Purchase of Property, Leasehold Improvements and Equipment	-338	-345	-408	-397	-	-	-300	-370	-399	-337
Purchase of Investment Securities	-726	-967	-3,214	-948	-2,385	111	-918	-492	-747	-1,695
Divestitures	4,895	-3.00	22	5.00	-14	-	0.00	-	-	521
Sale and/or Maturity of Investments	615	699	617	926	351	928	723	222	370	1,320
Net Cash From Financing Activities	-5,517	-2,636	-37	-435	-2,572	-1,250	-2,529	-2,309	439	-3,248
Net Cash From Continuing Financing Activities	-5,517	-2,636	-37	-435	-2,572	-1,250	-2,529	-2,309	439	-3,248
Issuance of Debt	-	-	1,491	183	1,301	-1,484	4,462	-	366	-366
Issuance of Common Equity	100	72	30	29	54	74	181	40	62	22
Repayment of Debt	-1,807	-508	-89	9.00	-2,887	1,198	-2,574	-893	467	-402
Repurchase of Common Equity	-3,500	-1,733	-962	-154	-624	-544	-4,022	-990	-	-2,022
Payment of Dividends	-341	-334	-368	-362	-362	-358	-401	-392	-390	-384
Other Financing Activities, Net	31	-133	-139	-140	-54	-136	-175	-74	-66	-96
Effect of Exchange Rate Changes	-18	12	5.00	-	-	-	-9.00	-3.00	18	-26
Cash Interest Paid	308	306	322	310	387	311	336	307	394	305
Cash Income Taxes Paid	435	504	77	849	454	91	110	457	272	59

This table presents The Cigna Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	61,759	153,226	155,774	155,451	154,889	143,885	152,761	155,881
Cash and Due from Banks	2,972	3,855	4,619	10,182	5,081	5,924	7,822	7,550
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	1,563	4,562	4,417	4,205	3,692	3,774	3,695	3,654
Separate Account Business Assets	8,423	7,839	8,465	9,086	8,337	7,278	7,430	7,278
Goodwill	6,164	44,505	44,602	44,648	45,811	45,811	44,259	44,370
Intangible Assets	345	39,003	36,562	35,179	34,102	32,492	30,863	29,417
Other Assets	40,055	50,641	54,151	48,766	57,866	48,606	58,692	63,612
Total Liabilities & Shareholders' Equity	61,759	153,226	155,774	155,451	154,889	143,885	152,761	155,881
Total Liabilities	47,999	112,154	110,395	105,065	107,705	99,131	106,410	114,638
Short-Term Debt	424	24,824	10,604	8,852	24,509	10,768	36,657	12,329
Accrued Interest Payable	3,963	7,071	7,347	8,515	7,322	7,978	9,955	9,387
Other Short-Term Payables	6,622	0.00	22,187	18,655	11,741	22,479	2,104	36,263
Long-Term Debt	5,199	39,523	31,893	29,545	31,125	28,100	28,155	28,937
Separate Account Business Liabilities	8,423	7,839	8,465	9,086	8,337	7,278	7,430	7,278
Other Long-Term Liabilities	23,368	32,897	29,899	30,412	24,671	22,528	22,109	20,444
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	49	37	35	58	54	66	107	0.00
Total Equity & Noncontrolling Interests	13,711	41,035	45,344	50,328	47,130	44,688	46,244	41,243
Total Preferred & Common Equity	13,711	41,028	45,338	50,321	47,112	44,675	46,223	41,033
Total Common Equity	13,711	41,028	45,338	50,321	47,112	44,675	46,223	41,033
Common Stock	3,014	27,755	28,310	28,979	29,578	30,237	30,673	31,292
Retained Earnings	15,800	15,088	20,162	28,575	32,593	37,940	41,652	43,519
Treasury Stock	-4,021	-104	-2,193	-6,372	-14,175	-21,844	-24,238	-31,437
Accumulated Other Comprehensive Income / (Loss)	-1,082	-1,711	-941	-861	-884	-1,658	-1,864	-2,341
Noncontrolling Interest	0.00	7.00	6.00	7.00	18	13	21	210

This table presents The Cigna Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	144,209	143,885	147,976	150,054	149,645	152,761	153,119	155,446	157,639	155,881
Cash and Due from Banks	7,079	5,924	7,935	9,585	8,497	7,822	8,439	6,788	5,888	7,550
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	3,744	3,774	3,837	3,884	3,924	3,695	3,607	3,551	3,594	3,654
Separate Account Business Assets	7,260	7,278	7,340	7,324	7,028	7,430	7,416	7,431	7,651	7,278
Goodwill	45,807	45,811	45,811	45,811	45,810	44,259	44,258	44,258	44,374	44,370
Intangible Assets	32,885	32,492	32,102	31,713	31,324	30,863	30,491	30,176	29,791	29,417
Other Assets	46,670	48,606	50,951	51,737	53,062	58,692	58,908	63,242	66,341	63,612
Total Liabilities & Shareholders' Equity	144,209	143,885	147,976	150,054	149,645	152,761	153,119	155,446	157,639	155,881
Total Liabilities	99,076	99,131	103,380	104,528	103,879	106,410	111,769	113,919	115,341	114,638
Short-Term Debt	10,358	10,768	28,387	31,307	10,719	36,657	39,905	10,992	45,365	12,329
Accrued Interest Payable	7,986	7,978	9,174	8,499	9,668	9,955	8,857	9,003	8,920	9,387
Other Short-Term Payables	22,771	22,479	7,166	7,539	26,672	2,104	3,215	35,378	2,775	36,263
Long-Term Debt	28,090	28,100	29,124	28,115	28,094	28,155	31,053	30,175	30,230	28,937
Separate Account Business Liabilities	7,260	7,278	7,340	7,324	7,028	7,430	7,416	7,431	7,651	7,278
Other Long-Term Liabilities	22,611	22,528	22,189	21,744	21,698	22,109	21,323	20,940	20,400	20,444
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	50	66	78	62	64	107	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	45,083	44,688	44,518	45,464	45,702	46,244	41,350	41,527	42,298	41,243
Total Preferred & Common Equity	45,041	44,675	44,502	45,445	45,691	46,223	41,181	41,332	42,095	41,033
Total Common Equity	45,041	44,675	44,502	45,445	45,691	46,223	41,181	41,332	42,095	41,033
Common Stock	29,399	30,237	30,336	30,440	30,567	30,673	30,296	31,052	31,190	31,292
Retained Earnings	37,041	37,940	38,841	39,936	40,982	41,652	40,978	42,132	42,480	43,519
Treasury Stock	-19,390	-21,844	-22,906	-23,053	-23,739	-24,238	-27,769	-29,410	-29,412	-31,437
Accumulated Other Comprehensive Income / (Loss)	-2,009	-1,658	-1,769	-1,878	-2,119	-1,864	-2,324	-2,442	-2,163	-2,341
Noncontrolling Interest	42	13	16	19	11	21	169	195	203	210

This table displays calculated financial ratios and metrics derived from The Cigna Group's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	4.73%	16.41%	216.54%	7.03%	5.82%	4.35%	6.60%	26.19%
EBITDA Growth	0.00%	23.27%	7.91%	149.33%	26.93%	-27.71%	15.03%	-20.44%	-5.15%
EBIT Growth	0.00%	29.51%	5.73%	102.30%	49.13%	-35.01%	20.34%	-27.70%	-3.66%
NOPAT Growth	0.00%	29.57%	26.21%	113.37%	49.47%	-33.58%	21.77%	-12.77%	-29.11%
Net Income Growth	0.00%	21.11%	18.55%	93.50%	65.80%	-36.15%	25.13%	-20.79%	-29.67%
EPS Growth	0.00%	21.98%	20.18%	27.51%	70.83%	-31.40%	35.94%	-18.78%	-30.30%
Operating Cash Flow Growth	0.00%	1.49%	-7.73%	151.59%	9.12%	-30.52%	20.37%	36.47%	-12.27%
Free Cash Flow Firm Growth	0.00%	0.00%	-388.51%	128.88%	-63.69%	-187.89%	452.51%	-176.97%	261.18%
Invested Capital Growth	0.00%	0.00%	443.87%	-16.64%	1.03%	15.81%	-18.67%	32.94%	-25.78%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	18.61%	4.93%	-0.12%	-0.28%	2.24%	7.12%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	17.91%	34.19%	-27.16%	2.95%	-12.31%	21.92%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	16.00%	49.29%	-33.90%	3.98%	-17.08%	37.35%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	16.86%	47.67%	-32.06%	16.06%	23.58%	1.39%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	19.54%	59.24%	-35.66%	1.25%	-2.10%	12.81%
EPS Q/Q Growth	0.00%	0.00%	0.00%	19.79%	60.90%	-33.40%	2.00%	-1.86%	14.34%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	39.12%	16.96%	-0.26%	-20.09%	-5.08%	56.59%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	71.15%	-128.26%	6.70%	-562.46%	217.11%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-0.13%	-0.70%	0.65%	0.05%	31.43%	-30.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-
EBITDA Margin	9.01%	10.60%	9.83%	7.74%	9.18%	6.27%	6.91%	5.16%	3.88%
EBIT Margin	7.48%	9.25%	8.40%	5.37%	7.48%	4.59%	5.30%	3.59%	2.74%
Profit (Net Income) Margin	4.63%	5.35%	5.45%	3.33%	5.16%	3.11%	3.73%	2.77%	1.55%
Tax Burden Percent	61.87%	61.90%	73.89%	77.93%	78.11%	79.82%	80.77%	97.44%	71.70%
Interest Burden Percent	100.00%	93.47%	87.79%	79.62%	88.31%	84.90%	87.24%	79.22%	78.59%
Effective Tax Rate	38.13%	38.10%	26.11%	22.07%	21.89%	20.18%	19.23%	2.56%	28.30%
Return on Invested Capital (ROIC)	0.00%	24.64%	4.83%	6.65%	10.88%	6.66%	8.34%	6.96%	4.96%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	19.09%	3.78%	4.20%	8.11%	4.61%	6.24%	4.24%	3.02%
Return on Net Nonoperating Assets (RNNOA)	0.00%	7.80%	4.82%	5.19%	6.85%	4.45%	6.41%	4.83%	3.66%
Return on Equity (ROE)	0.00%	32.44%	9.65%	11.84%	17.73%	11.11%	14.75%	11.79%	8.63%
Cash Return on Invested Capital (CROIC)	0.00%	-175.36%	-133.05%	24.81%	9.86%	-7.99%	28.93%	-21.32%	34.55%
Operating Return on Assets (OROA)	0.00%	6.25%	3.79%	5.34%	7.91%	5.15%	6.44%	4.69%	4.34%
Return on Assets (ROA)	0.00%	3.61%	2.46%	3.31%	5.46%	3.49%	4.54%	3.62%	2.45%
Return on Common Equity (ROCE)	0.00%	32.33%	9.63%	11.83%	17.71%	11.09%	14.73%	11.77%	8.59%
Return on Equity Simple (ROE_SIMPLE)	0.00%	16.28%	6.45%	11.29%	16.87%	11.50%	15.18%	11.62%	9.21%
Net Operating Profit after Tax (NOPAT)	1,843	2,388	3,014	6,431	9,612	6,384	7,774	6,781	4,807
NOPAT Margin	4.63%	5.72%	6.21%	4.18%	5.84%	3.67%	4.28%	3.50%	1.97%
Net Nonoperating Expense Percent (NNEP)	0.00%	5.55%	1.05%	2.45%	2.78%	2.05%	2.10%	2.72%	1.94%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	92.52%	90.75%	91.60%	94.63%	92.52%	95.41%	94.70%	96.41%	97.26%
Earnings before Interest and Taxes (EBIT)	2,979	3,858	4,079	8,252	12,306	7,998	9,625	6,959	6,704
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,589	4,424	4,774	11,903	15,108	10,921	12,562	9,994	9,479
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	1.59	1.41	1.55	2.19	1.87	1.87
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.47	0.43	0.42	0.54	0.45	0.31
Price to Earnings (P/E)	0.00	0.00	0.00	14.14	8.40	13.63	14.60	16.69	22.37
Dividend Yield	0.03%	0.02%	0.02%	0.02%	0.02%	1.81%	1.40%	1.67%	2.03%
Earnings Yield	0.00%	0.00%	0.00%	7.07%	11.90%	7.33%	6.85%	5.99%	4.47%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.25	1.12	1.20	1.57	1.29	1.34
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.72	0.60	0.71	0.72	0.74	0.45
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	9.25	6.58	11.34	10.42	14.34	11.68
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	13.34	8.07	15.48	13.60	20.60	16.52
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	17.12	10.34	19.40	16.84	21.14	23.04
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	11.60	9.60	17.22	15.12	12.13	10.69
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	4.59	11.41	0.00	4.85	0.00	3.31
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.41	1.57	0.94	0.76	1.18	0.87	1.40	1.00
Long-Term Debt to Equity	0.00	0.38	0.96	0.70	0.59	0.66	0.63	0.61	0.70
Financial Leverage	0.00	0.41	1.28	1.24	0.84	0.96	1.03	1.14	1.21
Leverage Ratio	0.00	4.49	3.92	3.57	3.25	3.18	3.25	3.26	3.52
Compound Leverage Factor	0.00	4.20	3.44	2.85	2.87	2.70	2.84	2.58	2.77
Debt to Total Capital	0.00%	29.01%	61.04%	48.36%	43.25%	54.11%	46.48%	58.30%	50.01%
Short-Term Debt to Total Capital	0.00%	2.19%	23.55%	12.07%	9.97%	23.84%	12.88%	32.98%	14.94%
Long-Term Debt to Total Capital	0.00%	26.82%	37.49%	36.29%	33.28%	30.27%	33.60%	25.33%	35.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.25%	0.04%	0.05%	0.07%	0.07%	0.09%	0.12%	0.25%
Common Equity to Total Capital	0.00%	70.74%	38.92%	51.59%	56.68%	45.82%	53.42%	41.58%	49.73%
Debt to EBITDA	0.00	1.27	13.48	3.57	2.54	5.09	3.09	6.49	4.35
Net Debt to EBITDA	0.00	0.60	12.67	3.18	1.87	4.63	2.62	5.70	3.56
Long-Term Debt to EBITDA	0.00	1.18	8.28	2.68	1.96	2.85	2.24	2.82	3.05
Debt to NOPAT	0.00	2.35	21.35	6.61	3.99	8.71	5.00	9.56	8.58
Net Debt to NOPAT	0.00	1.11	20.07	5.89	2.94	7.92	4.24	8.40	7.01
Long-Term Debt to NOPAT	0.00	2.18	13.11	4.96	3.07	4.88	3.61	4.15	6.02
Noncontrolling Interest Sharing Ratio	0.00%	0.36%	0.17%	0.10%	0.11%	0.14%	0.16%	0.23%	0.39%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-16,995	-83,022	23,974	8,705	-7,651	26,970	-20,760	33,461
Operating Cash Flow to CapEx	873.32%	867.52%	0.00%	903.33%	946.07%	623.14%	668.42%	750.99%	737.06%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.68	0.45	1.00	1.06	1.12	1.22	1.31	1.58
Fixed Asset Turnover	0.00	26.69	15.86	34.24	38.17	44.10	48.67	51.86	66.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	19,383	105,419	87,876	88,783	102,818	83,622	111,163	82,509
Invested Capital Turnover	0.00	4.31	0.78	1.59	1.86	1.82	1.95	1.99	2.52
Increase / (Decrease) in Invested Capital	0.00	19,383	86,036	-17,543	907	14,035	-19,196	27,541	-28,654
Enterprise Value (EV)	0.00	0.00	0.00	110,070	99,356	123,844	130,900	143,326	110,735
Market Capitalization	0.00	0.00	0.00	72,151	71,076	73,219	97,877	86,208	76,809
Book Value per Share	$0.00	$54.65	$166.31	$121.41	$139.29	$142.15	$146.12	$157.96	$147.52
Tangible Book Value per Share	$0.00	$28.71	($172.19)	($95.94)	($81.67)	($98.97)	($109.99)	($98.76)	($117.76)
Total Capital	0.00	19,383	105,419	87,876	88,783	102,818	83,622	111,163	82,509
Total Debt	0.00	5,623	64,347	42,497	38,397	55,634	38,868	64,812	41,266
Total Long-Term Debt	0.00	5,199	39,523	31,893	29,545	31,125	28,100	28,155	28,937
Net Debt	0.00	2,651	60,492	37,878	28,215	50,553	32,944	56,990	33,716
Capital Expenditures (CapEx)	461	471	0.00	1,050	1,094	1,154	1,295	1,573	1,406
Net Nonoperating Expense (NNE)	0.00	156	368	1,311	1,123	964	992	1,409	1,029
Net Nonoperating Obligations (NNO)	0.00	5,623	64,347	42,497	38,397	55,634	38,868	64,812	41,266
Total Depreciation and Amortization (D&A)	610	566	695	3,651	2,802	2,923	2,937	3,035	2,775
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$10.69	$13.58	$23.17	$15.87	$21.54	$17.57	$12.25
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	380.06M	372.04M	351.85M	320.95M	297.06M	292.36M	273.68M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$10.54	$13.44	$22.96	$15.73	$21.30	$17.39	$12.12
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	380.06M	372.04M	351.85M	320.95M	297.06M	292.36M	273.68M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$13.58	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	380.06M	372.04M	351.85M	320.95M	297.06M	292.36M	273.68M
Normalized Net Operating Profit after Tax (NOPAT)	1,843	2,388	3,014	6,431	9,612	6,384	7,774	6,781	4,807
Normalized NOPAT Margin	4.63%	5.72%	6.21%	4.18%	5.84%	3.67%	4.28%	3.50%	1.97%
Pre Tax Income Margin	7.48%	8.64%	7.37%	4.27%	6.60%	3.90%	4.62%	2.85%	2.16%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.29%	0.18%	24.74%	20.41%	26.99%	41.48%
Augmented Payout Ratio	7.54%	122.09%	12.93%	39.10%	47.79%	167.58%	132.57%	69.51%	227.66%

This table displays calculated financial ratios and metrics derived from The Cigna Group's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.97%	-1.12%	5.58%	7.10%	4.43%	9.34%	19.24%	24.40%	27.90%	32.75%
EBITDA Growth	46.03%	15.28%	18.56%	-1.28%	-34.28%	-51.66%	-57.83%	3.33%	-25.35%	129.78%
EBIT Growth	60.67%	22.81%	25.02%	-1.53%	-41.90%	-72.34%	-79.53%	5.21%	-28.89%	332.66%
NOPAT Growth	61.01%	-12.12%	31.85%	-0.42%	-42.50%	164.06%	-167.34%	7.51%	-37.50%	-43.82%
Net Income Growth	69.91%	7.38%	7.76%	-3.82%	-47.84%	-9.41%	-116.23%	7.88%	-43.06%	38.75%
EPS Growth	86.88%	12.35%	13.67%	0.61%	-47.16%	-8.64%	-122.88%	10.77%	-44.51%	43.55%
Operating Cash Flow Growth	54.93%	-50.90%	147.68%	100.32%	-13.92%	-30.11%	-3.74%	-89.37%	-98.37%	255.28%
Free Cash Flow Firm Growth	298.65%	261.48%	-198.04%	-196.06%	-96.58%	-219.08%	22.37%	245.22%	-4,464.45%	225.30%
Invested Capital Growth	-18.19%	-18.67%	18.75%	21.34%	1.19%	32.94%	9.99%	-21.20%	39.39%	-25.78%
Revenue Q/Q Growth	3.40%	-3.35%	2.42%	4.63%	0.82%	1.20%	11.82%	9.16%	3.66%	5.04%
EBITDA Q/Q Growth	48.67%	-39.92%	-0.29%	10.86%	-1.03%	-55.81%	-31.66%	171.63%	-28.50%	36.02%
EBIT Q/Q Growth	66.30%	-47.80%	-1.11%	14.70%	-1.87%	-75.15%	-55.74%	489.53%	-33.67%	51.21%
NOPAT Q/Q Growth	66.98%	-59.54%	30.77%	12.70%	-3.58%	85.83%	-197.21%	279.92%	-43.95%	67.04%
Net Income Q/Q Growth	76.94%	-56.01%	6.87%	15.62%	-4.04%	-23.60%	-119.15%	868.40%	-49.36%	86.18%
EPS Q/Q Growth	83.44%	-57.41%	10.99%	16.04%	-3.66%	-26.37%	-127.79%	661.86%	-51.74%	90.49%
Operating Cash Flow Q/Q Growth	163.91%	-36.06%	139.54%	-50.44%	13.40%	-48.09%	229.93%	-94.52%	-82.64%	11,230.43%
Free Cash Flow Firm Q/Q Growth	24.55%	-5.46%	-171.15%	-14.66%	104.43%	-3,392.66%	57.34%	314.51%	-233.23%	194.53%
Invested Capital Q/Q Growth	-3.36%	0.05%	22.11%	2.78%	-19.41%	31.43%	1.03%	-26.37%	42.57%	-30.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	9.63%	5.99%	5.83%	6.18%	6.06%	2.65%	2.06%	5.13%	3.54%	4.58%
EBIT Margin	8.09%	4.37%	4.22%	4.62%	4.50%	1.10%	0.72%	3.91%	2.50%	3.60%
Profit (Net Income) Margin	5.92%	2.69%	2.81%	3.11%	2.96%	2.23%	-0.38%	2.69%	1.32%	2.33%
Tax Burden Percent	79.58%	89.99%	81.57%	80.15%	78.75%	588.83%	-268.35%	81.90%	69.21%	76.46%
Interest Burden Percent	91.99%	68.55%	81.73%	83.85%	83.45%	34.31%	19.70%	84.14%	76.02%	84.73%
Effective Tax Rate	20.42%	10.01%	18.43%	19.85%	21.25%	-488.83%	368.35%	18.10%	30.79%	23.54%
Return on Invested Capital (ROIC)	12.62%	5.25%	6.73%	7.25%	7.98%	12.94%	-3.67%	7.32%	3.90%	6.95%
ROIC Less NNEP Spread (ROIC-NNEP)	12.10%	5.25%	6.13%	6.67%	7.24%	8.85%	-2.33%	6.71%	3.45%	6.43%
Return on Net Nonoperating Assets (RNNOA)	12.17%	5.40%	6.58%	7.29%	6.15%	10.07%	-3.48%	7.75%	4.48%	7.78%
Return on Equity (ROE)	24.79%	10.65%	13.31%	14.54%	14.14%	23.01%	-7.15%	15.07%	8.38%	14.73%
Cash Return on Invested Capital (CROIC)	27.22%	28.93%	-9.83%	-12.16%	5.34%	-21.32%	-4.65%	29.42%	-28.22%	34.55%
Operating Return on Assets (OROA)	9.87%	5.31%	5.17%	5.72%	5.80%	1.44%	0.97%	5.49%	3.71%	5.70%
Return on Assets (ROA)	7.23%	3.28%	3.44%	3.85%	3.81%	2.91%	-0.52%	3.78%	1.95%	3.69%
Return on Common Equity (ROCE)	24.75%	10.63%	13.29%	14.51%	14.11%	22.95%	-7.13%	15.02%	8.35%	14.67%
Return on Equity Simple (ROE_SIMPLE)	14.87%	0.00%	15.45%	15.00%	12.01%	0.00%	9.36%	9.61%	7.96%	0.00%
Net Operating Profit after Tax (NOPAT)	3,020	1,222	1,598	1,801	1,736	3,227	-1,076	1,936	1,085	1,813
NOPAT Margin	6.43%	2.69%	3.44%	3.70%	3.54%	6.51%	-1.94%	3.20%	1.73%	2.75%
Net Nonoperating Expense Percent (NNEP)	0.52%	0.00%	0.60%	0.58%	0.74%	4.09%	-1.35%	0.61%	0.45%	0.52%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	91.91%	95.63%	95.78%	95.38%	95.50%	98.90%	99.28%	96.09%	97.50%	96.40%
Earnings before Interest and Taxes (EBIT)	3,795	1,981	1,959	2,247	2,205	548	401	2,364	1,568	2,371
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4,521	2,716	2,708	3,002	2,971	1,313	1,142	3,102	2,218	3,017
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.83	2.19	1.68	1.80	1.82	1.87	2.58	2.27	2.30	1.87
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.45	0.54	0.40	0.44	0.44	0.45	0.52	0.44	0.42	0.31
Price to Earnings (P/E)	12.44	14.60	11.01	12.22	15.63	16.69	29.33	25.33	31.87	22.37
Dividend Yield	1.61%	1.40%	1.83%	1.70%	1.71%	1.67%	1.40%	1.59%	1.57%	2.03%
Earnings Yield	8.04%	6.85%	9.09%	8.18%	6.40%	5.99%	3.41%	3.95%	3.14%	4.47%
Enterprise Value to Invested Capital (EV/IC)	1.36	1.57	1.22	1.25	1.34	1.29	1.50	1.55	1.41	1.34
Enterprise Value to Revenue (EV/Rev)	0.63	0.72	0.67	0.70	0.60	0.74	0.83	0.60	0.73	0.45
Enterprise Value to EBITDA (EV/EBITDA)	9.34	10.42	9.57	10.16	9.97	14.34	20.04	15.07	21.45	11.68
Enterprise Value to EBIT (EV/EBIT)	12.31	13.60	12.40	13.17	13.54	20.60	31.27	23.28	34.16	16.52
Enterprise Value to NOPAT (EV/NOPAT)	17.02	16.84	18.07	19.29	20.71	21.14	32.38	24.00	35.17	23.04
Enterprise Value to Operating Cash Flow (EV/OCF)	10.52	15.12	10.66	10.19	9.13	12.13	14.53	13.67	25.20	10.69
Enterprise Value to Free Cash Flow (EV/FCFF)	4.51	4.85	0.00	0.00	25.32	0.00	0.00	4.65	0.00	3.31
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.85	0.87	1.29	1.31	0.85	1.40	1.72	0.99	1.79	1.00
Long-Term Debt to Equity	0.62	0.63	0.65	0.62	0.61	0.61	0.75	0.73	0.71	0.70
Financial Leverage	1.01	1.03	1.07	1.09	0.85	1.14	1.49	1.16	1.30	1.21
Leverage Ratio	3.22	3.25	3.31	3.31	3.23	3.26	3.50	3.51	3.49	3.52
Compound Leverage Factor	2.96	2.23	2.71	2.77	2.70	1.12	0.69	2.95	2.65	2.99
Debt to Total Capital	46.00%	46.48%	56.32%	56.62%	45.89%	58.30%	63.18%	49.78%	64.12%	50.01%
Short-Term Debt to Total Capital	12.39%	12.88%	27.80%	29.83%	12.67%	32.98%	35.53%	13.29%	38.48%	14.94%
Long-Term Debt to Total Capital	33.61%	33.60%	28.52%	26.79%	33.22%	25.33%	27.65%	36.49%	25.64%	35.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.11%	0.09%	0.09%	0.08%	0.09%	0.12%	0.15%	0.24%	0.17%	0.25%
Common Equity to Total Capital	53.89%	53.42%	43.58%	43.30%	54.02%	41.58%	36.67%	49.98%	35.71%	49.73%
Debt to EBITDA	3.15	3.09	4.43	4.59	3.41	6.49	8.42	4.83	9.72	4.35
Net Debt to EBITDA	2.57	2.62	3.82	3.85	2.66	5.70	7.42	4.03	8.97	3.56
Long-Term Debt to EBITDA	2.30	2.24	2.24	2.17	2.47	2.82	3.68	3.54	3.89	3.05
Debt to NOPAT	5.74	5.00	8.36	8.72	7.07	9.56	13.61	7.69	15.95	8.58
Net Debt to NOPAT	4.68	4.24	7.21	7.31	5.53	8.40	11.99	6.42	14.70	7.01
Long-Term Debt to NOPAT	4.19	3.61	4.24	4.12	5.12	4.15	5.95	5.64	6.38	6.02
Noncontrolling Interest Sharing Ratio	0.17%	0.16%	0.19%	0.17%	0.18%	0.23%	0.31%	0.32%	0.32%	0.39%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	21,598	20,418	-14,527	-16,657	738	-24,314	-11,277	24,190	-32,229	30,467
Operating Cash Flow to CapEx	971.30%	608.41%	1,232.35%	627.71%	0.00%	0.00%	1,613.33%	71.62%	11.53%	1,546.59%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.22	1.22	1.23	1.24	1.29	1.31	1.35	1.40	1.49	1.58
Fixed Asset Turnover	46.64	48.67	49.12	49.68	49.41	51.86	54.44	57.70	60.70	66.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	83,581	83,622	102,107	104,948	84,579	111,163	112,308	82,694	117,893	82,509
Invested Capital Turnover	1.96	1.95	1.96	1.96	2.25	1.99	1.89	2.29	2.25	2.52
Increase / (Decrease) in Invested Capital	-18,578	-19,196	16,125	18,458	998	27,541	10,201	-22,254	33,314	-28,654
Enterprise Value (EV)	113,973	130,900	124,223	131,506	113,651	143,326	168,868	128,480	166,757	110,735
Market Capitalization	82,512	97,877	74,553	81,588	83,260	86,208	106,180	93,906	96,847	76,809
Book Value per Share	$147.62	$146.12	$149.81	$153.60	$154.37	$157.96	$140.86	$145.50	$150.58	$147.52
Tangible Book Value per Share	($110.29)	($109.99)	($112.47)	($108.42)	($106.23)	($98.76)	($114.82)	($116.53)	($114.72)	($117.76)
Total Capital	83,581	83,622	102,107	104,948	84,579	111,163	112,308	82,694	117,893	82,509
Total Debt	38,448	38,868	57,511	59,422	38,813	64,812	70,958	41,167	75,595	41,266
Total Long-Term Debt	28,090	28,100	29,124	28,115	28,094	28,155	31,053	30,175	30,230	28,937
Net Debt	31,369	32,944	49,576	49,837	30,316	56,990	62,519	34,379	69,707	33,716
Capital Expenditures (CapEx)	338	345	408	397	0.00	0.00	300	370	399	337
Net Nonoperating Expense (NNE)	242	0.00	292	291	287	2,120	-864	307	260	277
Net Nonoperating Obligations (NNO)	38,448	38,868	57,511	59,422	38,813	64,812	70,958	41,167	75,595	41,266
Total Depreciation and Amortization (D&A)	726	735	749	755	766	765	741	738	650	646
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$9.07	$3.89	$4.28	$4.96	$4.79	$3.54	($0.97)	$5.51	$2.65	$5.06
Adjusted Weighted Average Basic Shares Outstanding	305.74M	297.06M	295.87M	295.98M	292.62M	292.36M	284.07M	279.55M	278.15M	273.68M
Adjusted Diluted Earnings per Share	$8.97	$3.82	$4.24	$4.92	$4.74	$3.49	($0.97)	$5.45	$2.63	$5.01
Adjusted Weighted Average Diluted Shares Outstanding	305.74M	297.06M	295.87M	295.98M	292.62M	292.36M	284.07M	279.55M	278.15M	273.68M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	305.74M	297.06M	295.87M	295.98M	292.62M	292.36M	284.07M	279.55M	278.15M	273.68M
Normalized Net Operating Profit after Tax (NOPAT)	3,020	1,222	1,598	1,801	1,736	384	281	1,936	1,085	1,813
Normalized NOPAT Margin	6.43%	2.69%	3.44%	3.70%	3.54%	0.77%	0.51%	3.20%	1.73%	2.75%
Pre Tax Income Margin	7.44%	2.99%	3.45%	3.88%	3.75%	0.38%	0.14%	3.29%	1.90%	3.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	20.51%	20.41%	20.29%	20.61%	25.99%	26.99%	38.48%	38.08%	46.01%	41.48%
Augmented Payout Ratio	129.43%	132.57%	125.01%	113.76%	89.28%	69.51%	177.14%	193.63%	211.91%	227.66%

Frequently Asked Questions About The Cigna Group's Financials

When does The Cigna Group's fiscal year end?

According to the most recent income statement we have on file, The Cigna Group's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has The Cigna Group's net income changed over the last 8 years?

The Cigna Group's net income appears to be on an upward trend, with a most recent value of $3.78 billion in 2024, rising from $1.84 billion in 2016. The previous period was $5.37 billion in 2023.

How has The Cigna Group revenue changed over the last 8 years?

Over the last 8 years, The Cigna Group's total revenue changed from $39.84 billion in 2016 to $244.41 billion in 2024, a change of 513.5%.

How much debt does The Cigna Group have?

The Cigna Group's total liabilities were at $114.64 billion at the end of 2024, a 7.7% increase from 2023, and a 138.8% increase since 2017.

How much cash does The Cigna Group have?

In the past 7 years, The Cigna Group's cash and equivalents has ranged from $2.97 billion in 2017 to $10.18 billion in 2020, and is currently $7.55 billion as of their latest financial filing in 2024.

How has The Cigna Group's book value per share changed over the last 8 years?

Over the last 8 years, The Cigna Group's book value per share changed from 0.00 in 2016 to 147.52 in 2024, a change of 14,752.0%.

Remove Ads

Related Companies

This page (NYSE:CI) was last updated on 4/17/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Cigna Group (CI) Financials

Frequently Asked Questions About The Cigna Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

The Cigna Group (CI) Financials

Annual Income Statements for The Cigna Group

Quarterly Income Statements for The Cigna Group

Annual Cash Flow Statements for The Cigna Group

Quarterly Cash Flow Statements for The Cigna Group

Annual Balance Sheets for The Cigna Group

Quarterly Balance Sheets for The Cigna Group

Annual Metrics and Ratios for The Cigna Group

Quarterly Metrics and Ratios for The Cigna Group

Frequently Asked Questions About The Cigna Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools